Tonix Pharmaceuticals Holding Corp.
已更新

"Balanced Biotech Strategy"

1 485
Trading TNXP requires careful consideration of both the high reward potential and the significant risks involved. Combining technical analysis for short-term trades with a fundamental approach for long-term investments, while employing robust risk management techniques, can help navigate the volatile nature of this stock. Always stay informed about the latest company developments and market conditions to make well-informed decisions.
交易進行
快照
註釋
I started investing in this stock before its split in January 2023, with a consistent accumulation strategy that brought my average cost to 16 cents. Leveraging thorough technical analysis, extensive research, and a personal connection to the company, I identified its long-term potential early on.

Recently, I took profits at $1.90 while maintaining a core position for the long term. This approach balances steady growth with strategic profit-taking, reflecting my confidence in the company's trajectory.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。